-
CMSC
Brief Test Battery Predicts Driving Ability in MS
A 30-minute test battery helps to accurately predict driving performance in patients with relapsing-remitting MS.
Medscape Medical News, June 3, 2012
-
ASCO
T-DM1 Improves Outcomes in HER2-Positive Breast Cancer
The experimental agent T-DM1 significantly improves progression-free survival in HER2-positive metastatic breast cancer, compared with standard therapy.
Medscape Medical News, June 3, 2012
-
Price for Intermittent ADT in Advanced Prostate Cancer
A landmark trial now has survival data and a conclusion.
Medscape Medical News, June 3, 2012
-
ASCO
Bevacizumab Boosts Outcomes in Resistant Ovarian Cancer
Bevacizumab added to chemotherapy increased progression-free survival in patients with platinum-resistant ovarian cancer.
Medscape Medical News, June 2, 2012
-
ASCO
PD-1 Agent 'Breaks Ceiling' in Cancer Immunotherapy
Medscape Medical News, June 2, 2012
-
Exercise Worsens a CV Risk Factor in 10% of People
Heartwire, June 1, 2012
-
AUA
AUA Issues New Guidelines at Annual Meeting
Medscape Medical News, June 1, 2012
-
AACE
The Game Plan, A Step-By-Step Initiative for Type 2 Diabetes
Medscape Medical News, June 1, 2012
-
CMSC
Preventing Misdiagnosis of MS
Medscape Medical News, June 1, 2012
-
FDA, Others Recommend Use of Blunt-Tip Suture Needles
Medscape Medical News, June 1, 2012
-
AUA
Avanafil Effective in Difficult-to-Treat ED
Medscape Medical News, June 1, 2012
-
Patients With CAP Leave Hospital Sooner With 3-Step Approach
Medscape Medical News, June 1, 2012